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Abstract
Background: Head and neck cancer (HNC) is the sixth most common cancer worldwide, and the functional,
psychological and social consequences of HNC cancer and its treatment can be severe and chronic. Dysphagia
(swallowing problems) affects up to two thirds of patients undergoing combined chemoradiotherapy. Recent
reviews suggest that prophylactic swallowing exercises may improve a range of short- and long-term outcomes;
however, the importance of psychological and behavioural factors on adherence to swallowing exercises has not
been adequately studied. This study aims to develop and test the feasibility of a Swallowing intervention Package
(SiP) designed in partnership with patients, speech and language therapists (SLTs) and other members of the head
and neck multi-disciplinary team (MDT), for patients undergoing chemoradiotherapy (CRT) or radiotherapy (RT) for
head and neck cancer.
Methods/design: This feasibility study uses quantitative and qualitative research methods, within a quasi-experimental
design, to assess whether patients will tolerate and adhere to the SiP intervention, which aspects of the intervention
can be implemented and which cannot, whether treatment fidelity can be achieved across different contexts, whether
study processes and outcome measures will be feasible and acceptable and to what extent the intervention is likely to
have an impact on swallowing dysfunction and quality of life. Patients are being recruited from five sites in Scotland
and England (three interventions and two usual care). The SLT based in the relevant intervention centre teaches the
exercise programme and provides supporting materials. A combination of patient-reported outcome measures
(PROMs), adherence measures and clinical swallowing assessments are used prior to intervention (baseline), at the end
of treatment, 3 and 6 months post-treatment.
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Discussion: This collaborative study has taken a unique approach to the development of a patient-centred and
evidence-based swallowing intervention. The introduction of an e-SiP app provides an exploration of the use of
technology in delivering this intervention. The study provides an opportunity to examine the feasibility of delivering
and participating in a supported swallowing intervention across several different NHS sites and will provide the
evidence needed to refine intervention and study processes for a future trial.
Trial registration: NCRI portfolio, 18192 & 20259
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Background
Head and neck cancer (HNC) is the sixth most common
cancer worldwide [1]. Currently, there are more than
62,000 people living with head and neck cancer in the UK
[2]. In Scotland, where incidence rates are significantly
higher than the rest of the UK, a 37 % rise is predicted in
the next 10 years [3]. Patients are surviving longer and,
due to human papillomavirus, are younger at diagnosis.
The functional, psychological and social consequences of
HNC cancer and its treatment can be severe and chronic.
Treatment includes a combination of surgery, radiother-
apy and/or chemotherapy, and the side effects of these
can interfere with some of the most fundamental aspects
of daily living, including eating, drinking, communication
and appearance. Improved survival has been achieved at
the expense of increased morbidity, especially in relation
to swallowing problems or ‘dysphagia’ [4].
Dysphagia affects up to two thirds of patients under-
going combined chemoradiotherapy (CRT) [5]. Patients
report major deterioration in their swallowing, and little
evidence of recovery over time, with younger survivors
reporting the most severe problems [6]. Early side effects
of CRT1 include pain, mucositis (inflammation of the
mucous membranes) and xerostomia (dry mouth). Late
effects include fibrosis (scarring) of the soft tissues, af-
fecting the safety and efficiency of swallowing [7, 8]. As-
piration rates (food or fluid entering the airway) are high
(≥60 %), leading to frequent hospitalisation for chest in-
fection, pneumonia and even death [5, 8]. The effects of
CRT contribute to significant weight loss, and 50–70 %
of patients require a feeding tube during or after treat-
ment [9]. Tube dependency reduces the need to swallow,
so increasing the likelihood of fibrosis of the muscles in-
volved in swallowing, and in the long-term, ‘disuse atro-
phy’, sometimes leading to complete inability to swallow.
Swallowing difficulties have a significant negative emo-
tional and physical impact on social eating, return to
work and everyday quality of life [7].
Recent reviews [10, 11] suggest that prophylactic swal-
lowing exercises may improve a range of short- and
long-term outcomes, as they increase the blood flow to
muscles, reducing or preventing fibrosis, and maintain-
ing the range and speed of swallowing movements.
However, not all trials have had positive results [12–14],
and a number of questions remain, including the opti-
mal timing, selection and duration of exercises, the
achievement of intervention fidelity and, importantly,
the support necessary to improve adherence [10]. Only
13–14 % of participants practise swallowing exercises as
recommended [15, 16]. An unpublished study found that
patients with high levels of pain during treatment strug-
gled with performing regular exercises and that it was
difficult to focus on preventative exercises in the context
of facing a potentially life-limiting disease. Furthermore,
the intervention was not seen as integral to their overall
care [17]. There is, however, evidence that those who
maintain their exercise schedule achieve improved swal-
lowing outcomes [18] and are significantly less likely to
need a feeding tube [19]—an important consideration
given that feeding tubes are associated with significantly
poorer quality of life [20].
The multi-dimensional nature and impact of swal-
lowing difficulties and the importance of psychological
and behavioural factors on adherence to swallowing
exercises has not been adequately studied [21, 22].
The need for further research, particularly prospective
randomised trials to investigate the benefit of an
intervention which includes pre-, peri- and post-
treatment swallowing exercises has been highlighted
repeatedly [10, 23, 24].
This study aims to develop and test the feasibility of a
Swallowing intervention Package (SiP) designed in part-
nership with patients, speech and language therapists
(SLTs) and other members of the head and neck multi-
disciplinary team (MDT), for patients undergoing pri-
mary or adjuvant CRT or radiotherapy for head and
neck cancer. A development phase (phase 1), informed
by focus groups with patients and consensus workshops
with professionals, produced a swallowing exercise
schedule, staff manual and SiP package for patients, in-
cluding written materials, videos, reminder materials
and an electronic e-SiP ‘app’ to support adherence. This
protocol, based on version 5 (24.2.16) describes the
feasibility study (phase 2) for this complex intervention,
which aims to answer four research questions in prepar-
ation for a future multi-centre trial:
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1. What is the feasibility of delivery and potential
impact of the SiP for patients and head and neck
cancer teams?
2. What are the barriers and facilitators to adherence
and fidelity to the SiP?
3. Does an e-support system (e-SiP) have potential to
support patients to perform their exercises and for
collecting patient-reported data through video
diaries?
4. Are the study processes and outcome measures
feasible and acceptable to patients and staff?
Methods/design
This feasibility study uses quantitative and qualitative re-
search methods, within a quasi-experimental parallel
group design, to assess whether patients will tolerate
and adhere to the SiP intervention, which aspects of the
intervention can be implemented and which cannot,
whether treatment fidelity can be achieved across differ-
ent contexts, whether study processes and outcome
measures will be feasible and acceptable and to what ex-
tent the intervention is likely to have an impact on swal-
lowing dysfunction and quality of life.
Forty patients will be recruited to the SiP intervention
group, from three hospital outpatient settings in
Scotland, and a maximum of 30 patients will be re-
cruited to a ‘usual care’ group, from sites in Scotland
and the North East of England. This is a pragmatic de-
sign to allow for different service delivery models in dif-
ferent geographical areas. There is a trade-off between
precision (recruitment parameter of numbers retained
by study endpoint) and number of patients recruited to
the study. A sample size of 59 is thought to be sufficient
to identify any potential problems in feasibility which have
a 5 % probability of occurrence at least once, with 95 %
confidence [25]. Several new sites have expressed an inter-
est in participating and are being adopted in order to en-
hance recruitment.
To identify the variety of practical issues and problems
faced by a ‘real world’ and inclusive ‘typical’ cohort of pa-
tients with head and neck cancer and the applicability of
the intervention across this cohort, we will include
people with/without prophylactic feeding tubes, from
different demographic, diagnostic (e.g. oral, pharyngeal,
laryngeal) and treatment (CRT and radiotherapy alone)
groups.
Inclusion criteria:
Patients diagnosed with an index primary mucosal squa-
mous cell carcinoma of oral cavity, nasopharynx, pharynx
or larynx or unknown primary, who are planned for che-
moradiotherapy or radiotherapy ≥30 fractions. This may
include patients who have undergone surgery before their
chemoradiation or radiotherapy. Patients must be able to
give informed consent.
Exclusion criteria:
Patients with synchronous or metachronous head and
neck cancer primaries, those undergoing palliative treat-
ment, nonEnglish speakers, previously diagnosed dyspha-
gia unrelated to HNC and those who have undergone
total glossectomy or total laryngectomy.
Screening, recruitment and consent
All potentially eligible patients will be identified from
the head and neck cancer MDT meetings. Eligible pa-
tients will be seen at routine appointments for treatment
planning and invited to participate in the study by a
member of the clinical team. The e-SiP app is being
tested in Tayside, where patients eligible for the inter-
vention are also eligible for the app version. The dele-
gated individual will explain the study to the patient,
give them the Patient Information Sheet (PIS) and an-
swer any questions. Consent will be sought a mini-
mum of 24 h later by a research nurse. The PIS for
the intervention group explains that a Swallowing
intervention Package of exercises and support has
been developed and that we are now asking people to
try this out and report their experiences, with the
hope that we will be able to use these findings to
underpin a larger trial. The PIS for the control group
explains that patients will have no change to their
usual care and will continue to have the swallowing
support normally provided by their treatment centre.
Both intervention and control patients are informed
that taking part in the study will not affect any usual
treatment that they may receive and that taking part
may not benefit them personally.
At the time of consent the participant will also be
asked to fill in the baseline study questionnaires, and
a standard letter will be sent to their GP specifying
the recruiting hospital and whether or not the patient
is in the intervention or ‘usual care’ group. All pa-
tients will also be asked whether they and/or a close
family member or friend would be willing to be
approached for a subsequent qualitative interview
with the research fellow, between 6 weeks and 3
months after treatment finishes, to explore their
experiences.
In order to assess the representativeness of the
sample, a screening log will record the number of pa-
tients who are (a) ineligible, (b) refuse to participate
in the intervention or control cohorts and (c) decline
specific aspects of the study (e.g. clinical assessments,
questionnaires), as well as their reasons, where pos-
sible. The rights of patients to refuse to participate or
withdraw without giving reasons will be respected. If
patients do volunteer a reason for refusal, or for
wishing not to use the e-SiP app versions, then these
will be logged.
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Clinical and socioeconomic characteristics
At the point of recruitment, all participants are allocated a
unique ID number. At baseline, the following data will be
extracted from NHS patient records and recorded by re-
search nurses/clinical teams in the study case report form:
Date of birth, sex, ethnicity, Index of Multiple
Deprivation derived from patient’s residential postcode,
education level, work status, social support, tumour type,
anatomic site, TNM stage, size and position of primary
tumour, smoking (current/ex-smoker and pack years),
use of alcohol, body mass index, weight, surgery,
planned CRT regime including chemotherapy regime,
type of radiotherapy (e.g. intensity-modulated radiation
therapy (IMRT) or conventional), number of fractions,
radiation field, feeding tube and feeding regime (whether
in situ or planned).
At the end of treatment, CRT details will be checked
and amended as necessary to record the treatment actu-
ally delivered, including overall radiation dose to primary
clinical target volume and dose to the constrictor mus-
cles. Additional data will be recorded on:
Method of feeding throughout treatment, any admissions
to hospital, analgesic regime, treatment complications and
weight loss will be recorded on the post-treatment case re-
port form and updated as appropriate. Any adverse events
which are not expected as a relatively common side effect
of CRT (e.g. aspiration pneumonia, death) will also be re-
corded on this form.
All case report forms are pseudonymised by their
unique ID number, before being transferred to the Re-
search Team for further analysis. Relevant staff within
the project team have undergone Good Clinical Practice
(GCP) training.
Outcome measures
A combination of patient-reported outcome measures
(PROMs), adherence measures and clinical swallowing
assessments will be used prior to intervention (baseline),
at the end of treatment, 3 and 6 months post-treatment
(see Fig. 1). Data will provide key estimates of the vari-
ability for primary and secondary outcomes to inform
the best primary outcome measure and sample size esti-
mations for a future trial. Where possible, data are being
collected during or after routine clinic appointments in
order to enhance retention and complete follow-up.
Patient-reported outcome measures
Swallowing function will be measured by the MD
Anderson Dysphagia Inventory (MDADI) [26] (likely pri-
mary outcome measure). Quality of life will be measured
by the European Organisation for Research and Treat-
ment of Cancer (EORTC) Quality of Life Questionnaire
for cancer patients (QLQ-C30) with the supplementary
Head and Neck Module (HN35) [27, 28] and the EuroQol
five dimensions questionnaire (EQ-5D) [29].
Adherence measures
We have developed a ‘Rehabilitation Intervention Beliefs’
(RIB) questionnaire, based on Cooper et al.’s [30] work
on exploring patients’ beliefs about cardiac rehab, to as-
sess beliefs that may affect adherence to the SIP, includ-
ing perceived necessity, concerns, practical barriers and
perceived suitability for the intervention.
The RIB and Brief Illness Perceptions (Brief IPQ) [31]
questionnaires will assess motivation towards the SIP as
well as illness cognitions and emotional representations.
At the 3-month data collection point, patients will be
asked to complete the post-intervention RIB question-
naire, which includes three additional questions about
the patient’s overall experience of the SiP. Structured
diary record cards (Fig. 2) will enable recording of daily
exercise patterns and frequency, factors which interfered
with or promoted adherence, e.g. pain, and any com-
ments about undertaking the exercises. Furthermore, in
a small sub-sample of patients, we will pilot the use of
technology (e-SIP app) for reporting on adherence; iPads
will be provided for the recording of video diaries, enab-
ling real-time data on the performance of swallowing ex-
ercises and experiences to be collected.
Clinical assessments of swallowing ability
1) 100 ml Water Swallow Test (WST) [32]. The WST
records the duration and number of swallows
required to swallow 100 ml of water. Quick,
inexpensive, with good reliability and validity,
excellent patient and clinician acceptability, it is
sensitive to measure changes over time and follows
the expected pattern in differentiating between
different cancer treatment regimes. Unlike
instrumental tests, the WST does not provide any
information on swallow pathophysiology. It has
therefore been selected to provide interim information
about changes to swallowing function, as an adjunct
to the more expensive Fibreoptic Endoscopic
Evaluation of Swallowing (FEES) assessment.
2) Performance Status Scale for HNC (PSS-HN) [33].
This three-item scale evaluates dietary texture
restrictions and social eating. It has excellent
discriminatory properties, good inter-rater reliability
and sensitivity to differences in performance and
change over time.
3) FEES. This instrumental test allows quantification of
endpoints of swallowing pathophysiology,
swallowing efficiency and airway invasion (laryngeal
penetration and aspiration) [34]. The alternative to
FEES—videofluoroscopy (VF) [35]—exposes patients
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to radiation, is more expensive, less practical to
implement and is associated with greater loss to
follow up. Blinded FEES assessments will be
analysed by the SLT consultants using reliability
testing. This test is used routinely in clinical practice
but is not carried out for all head and neck cancer
patients. An information leaflet is always provided to
patients and informed consent is taken before the
FEES is carried out.
4) Functional Oral Intake Scale (FOIS) [36]. This scale
is scored according to a level that best describes the
patient’s oral intake. There are seven levels from
level 1: nothing by mouth to level 7: total oral diet
with no restrictions.
Intervention (SiP)
The SLT based in the relevant centre will teach the exer-
cise programme and provide supporting materials, in-
cluding diary record sheets, a study water bottle, a SiP
patient manual2 (Fig. 3), swallowing exercise videos and
an iPad containing the e-SiP (which will be piloted in a
small number of patients) (Figs. 4 and 5). SLTs reviewed
the current literature on prophylactic exercises alongside
the evidence base for specific swallowing exercises linked
Fig. 1 Flow diagram of data collection points for SiP study
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to the pathophysiology of post-irradiated dysphagia and
achieved consensus over the exercise regime for SiP (see
Table 1). A staff manual was developed based on the
Behaviour Change Taxonomy (BCT) [37]. The original 26
point taxonomy was reduced to a 20-point taxonomy
using staff consensus. During the consensus workshop
conducted as part of phase 1, a multi-disciplinary group of
staff reviewed the BCT and devised the manual based on
how this could be applied in the SiP intervention (for ex-
ample, in setting goals with patients), both for initial
delivery and ongoing patient support. An example page
from this manual is shown in Fig. 6. The aim of the man-
ual is to develop maximum intervention fidelity across the
different delivery sites [38]. A small number of interven-
tions will be recorded or observed to check the inclusion
of particular behaviours displayed by patients or staff dur-
ing intervention delivery.
This initial consultation will take place before the start
of CRT. At the end of the consultation, the SLT will
complete an intervention receipt questionnaire, detailing
Fig. 2 Diary record cards
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the main components of the intervention delivered and
an assessment of the patient’s understanding and motiv-
ation towards the intervention.
e-SiP delivery
Patients in Tayside who have expressed willingness to
trial the e-SiP app version will be provided with an iPad
during their initial intervention delivery appointment.
They will also be asked to sign an additional consent
form which sets out their responsibilities in taking care
of the iPad and the boundaries for appropriate use. Two
user guides are included with the iPads; the patient user
guides details the use of the e-SiP app. In addition, the
staff user guide explains the additional log-in functional-
ity that staff may access to change features, e.g. the
number of exercise repetitions, within the e-SiP app for
that particular patient. All staff delivering the iPad have
received training on encouraging the use of the e-SiP,
e.g. recording video diaries, over and above the basic
staff manual for the SiP delivery.
On-treatment review
During CRT, either the SLT or clinical nurse specialist
(CNS) will review each patient regularly, according to
usual on-treatment review practice in each centre.
Symptoms will be managed according to local treatment
and supportive care protocols. Additional on-treatment
review opportunities with nurses, therapy radiographers
and dietitians will be used to provide feedback on effort
and progress, encourage maintenance of the intervention
and monitor adherence to exercises. A weekly assess-
ment log based on the BCT will enable practitioners to
document the content of interactions about swallowing
that they have had with the patient during treatment,
allowing resource use, intervention fidelity and costs to
be estimated. In addition, a purposive sample of consul-
tations (pre-, during and post-treatment) between SLTs
and patients in each centre will be observed or recorded,
using an observation checklist [39]. Patients will be en-
couraged to bring a family member or friend with them
for intervention visits, in order that they can facilitate
and support aspects of the SiP at home.
Fig. 3 Picture of patient manuals and water bottle
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Data monitoring committee
Although considered, it was deemed that the project did
not justify the role of a separate Data Monitoring Com-
mittee (DMC). The intervention consists of clinically
validated swallowing exercises and assessments that are
used already in clinical practice, and there are no antici-
pated risks to participants over and above those related
to the patient’s cancer treatment. The role of the DMC
has therefore been subsumed into the function of the
Study Steering Committee, who have overseen the
monitoring of adverse events. Within this, MW, ND,
N H-W and EK, have formed the Data Management
Team to discuss day-to-day queries concerning data
entry and analysis.
Qualitative evaluation
Ten to 15 patient participants (and 5 carers) will be in-
vited for an in-depth interview between 6 weeks and 3
months after treatment finishes. Some of these interviews
may be joint patient/carer dyads. Purposive sampling will
be used to maximise the potential for including partici-
pants from different socio-demographic backgrounds,
with a range of swallowing difficulties, who adhered to the
exercises to varying degrees and used different adherence
support, e.g. paper based or e-SiP. Both those who partici-
pated in the intervention and a small number from the
‘usual care’ group will be included. The main research
fellow for the study will (a) conduct face-to-face or tele-
phone interviews with patient and carer participants, to
Fig. 4 Screenshot of e-SiP
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explore experiences, challenges and adherence to SiP and
to identify strategies used by patients (and carers) to over-
come any challenges, including which support measures
were most and least useful and (b) undertake face-to-face
or telephone interviews with 15 key members of staff
(SLTs, CNS’, clinic nurses, radiographers, dietitians)
from feasibility study sites to elicit views of the SiP and e-
SiP, problems with implementation and perceptions of
patient outcomes [40]. These data will provide important
insights into the intervention refinements necessary for a
future RCT.
Data analysis
All data will be entered from pseudonymised case report
forms (CRFs) onto a secure password protected database
based at the study coordinating centre. Quantitative data
Fig. 5 Screenshot of e-SiP
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will be entered onto a SPSS v21 database using a coding
manual. Qualitative data will be transcribed verbatim and
entered into N-VIVO for analysis. Data will be handled,
computerised and stored in accordance with the Data Pro-
tection Act 1998. All study data will be retained in accord-
ance with Research Governance and local policy.
Qualitative data will be analysed using framework ana-
lysis and quantitative outcome data using SPSS v21 or
Stata v14. Descriptive statistics will be used to summar-
ise demographic and clinical data, recruitment rates and
proportions of those participating, dropping out and
providing usable outcome measures. These will be used
to populate a CONSORT study flow chart. Missing data
problems will be explored to ascertain if missing at ran-
dom or not. Patient-reported and clinical swallowing
outcomes will be estimated between treatment-as-usual
and intervention groups as mean or median scores with
respective standard deviations or interquartile ranges.
Wherever possible, outcome descriptions, summaries and
comparisons will be presented together with estimates of
precision in accordance with stipulated CONSORT guide-
lines (www.consort-statement.org). As this is a feasibility
study, the data will not be pooled with any future main
trial data. This study is not powered to detect significant
differences between groups, and therefore, no formal tests
of statistical significance will be undertaken.
Statistical models utilising the repeated measures, with
baseline measures used as covariates in statistical models
will be used to ascertain likely key independent predic-
tors explaining variability of the range of possible out-
come measures in this feasibility study. We do not
expect to achieve significant differences from baseline to
follow-up measure(s) between or within groups as this
study is inadequately powered and is quasi-experimental;
however, we expect to estimate relative effect sizes (and
95 % CI) for each potential main outcome measure, cor-
relation between measurements, and intra-cluster (site)
correlation coefficient for use in sample size simulations
for a future randomised trial; this study aims to ascertain
if the data collection is sufficient to yield usable data in
hypothesis testing in a definitive multi-centre trial and
to assess whether the direction of effect is in favour of
the intervention. Preliminary psychometric validation of
the RIB will also be undertaken, including Cronbach’s
alpha (for internal consistency), correlation analyses for
test-retest reliability and construct validity. The EQ-5D
will be used to calculate quality-adjusted life years
(QALY) gains and used along with an assessment of re-
source implications to inform a full economic evaluation
in a future definitive trial. With respect to the analysis of
the e-SiP, the e-SiP itself is not considered part of the
intervention (it does not represent any change in actual
exercise protocol), but is a means of testing different
ways of data collection, improving any missing data
problem and supporting adherence. Although we intend
to incorporate the e-SiP data into our analysis, our sam-
ple of patients using the e-SiP will be very small due to
the available number of iPads. However, we will conduct
a sensitivity analysis whereby we analyse the data with
and without the e-SiP sub-sample to ascertain if there
are any changes to effect size and variance. We will as-
sess e-SiP use to see which aspects of the app patients
use most and to conduct a comparison of entries be-
tween the paper and e-SiP diaries.
Discussion
The potential for swallowing exercises to improve short-
and long-term outcomes in patients with head and neck
cancer is increasingly recognised, but the evidence base
remains limited.
The support of specialist SLTs and other members of
the MDT is known to be important, but the extent to
which patients routinely have access to SLTs before and
during treatment is extremely variable [41]. This is due
in part to our limited knowledge about the best ways to
deliver swallowing interventions and support people
who have or are at risk of developing swallowing diffi-
culties as a result of treatment for HNC.
Patients undergoing CRT experience significant fatigue
and other side effects, which are likely to challenge their
ability to perform swallowing exercises, but the experi-
ences of patients and the factors influencing adherence
Table 1 Swallowing exercises
Target number for each day
Exercise Session 1 Session 2 Session 3
Mendelsohn 10 10 10
Masako 10 10 10
Effortful swallow 10 10 10
Shaker 3× 1-min hold 3× 1-min hold 3× 1-min hold
30 head lifts 30 head lifts 30 head lifts
Jaw exercises (if instructed, once patient is no longer able
to insert three fingers between top and bottom teeth)
5× 30-s straight opening 5× 30-s straight opening 5× 30-s straight opening
5× 1-s jaw swing to each side 5× 1-s jaw swing to each side 5× 1-s jaw swing to each side
SLTs make the decision whether to reduce/remove an exercise depending on the individual patient
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to exercises on a day-to-day basis are largely unknown.
In this study, data collected relating to patient and carer
attitudes, beliefs and experiences during and after CRT
will provide important insights into potential barriers
and facilitators to exercise adherence in a range of real-
life contexts. These will inform future studies.
This collaborative study has taken a unique approach
to the development of a patient-centred and evidence-
based swallowing intervention, which aims to encourage
and support adherence to daily swallowing exercises
during and after CRT, whilst being practical for SLTs
and MDTs to implement for a wide range of patients.
The introduction of the e-SiP provides an exploration of
the use of technology in delivering this intervention,
which might be especially pertinent given the increasing
numbers of younger HNC patients.
Fig. 6 Taxonomy of behaviours for SiP
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We have worked in partnership with SLTs, patients
and carers to develop this complex intervention. The
study provides an opportunity to examine the feasibility
of delivering and participating in a supported swallowing
intervention across several different NHS sites and will
provide the evidence needed to refine intervention and
study processes for future research. We will collect a
broad range of qualitative and quantitative data, includ-
ing outcome measures, clinical assessments and inter-
view. This will result in a large amount of diverse data
which will inform a definitive multi-centre trial, based
on sound theoretical and empirical foundations, feasible
for patients and staff and implementable on a wide scale.
Dissemination plans
We will continue to engage and share findings with a
wide range of HNC specialists and SLTs across the UK
and Europe. Our study is on the National Cancer Re-
search Institute (NCRI) portfolios for Psychosocial On-
cology and Survivorship and Head and Neck Cancers.
We will discuss our findings and their implications with
the NCRI Clinical Studies Groups, Macmillan and HNC
charities and with staff and patients from participating
NHS Boards. We will present our work at National and
International meetings and will submit findings for pub-
lication in clinical peer-reviewed journals.
Trial status
The proposal for this study was peer reviewed and then
funded by the Chief Scientist Office in July 2014 (ref:
CZH/4/1052). Progress reports are submitted to the
funder on a regular basis, but no further input to the de-
sign, analysis, interpretation or writing up of the data is
given by the funder. iPads have been loaned by Throat
Cancer Foundation. Phase 1 was approved by NRES
Committee North East—Newcastle and North Tyneside
2 in October 2014 (REC:14/NE/1168; NRS R&D:
NRS14/ON593). Phase 2 was approved by the East of
Scotland Research Ethics Service (EoSRES) in October
2015 (REC: 15/ES/0106; NRS R&D: NRS15/ON703), and
participants are being recruited at time of submission.
All protocol amendments are communicated to relevant
R&D, ethics and research teams. Sponsorship, indemnity
and insurance are provided by the University of Stirling.
Target completion date for phase 2 is February 2017.
We are happy to share the protocol and supporting doc-
uments with other researchers.
Endnotes
1For the purposes of this protocol ‘CRT’ includes pa-
tients undergoing chemoradiotherapy or radiotherapy,
either as primary treatment or after surgery.
2This includes information and advice on normal swal-
lowing, importance of maintaining swallow, tips for
eating and drinking, swallowing exercises, diary record
cards, strategies for managing distress and anxiety and
resources for further information and support
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